| Detected | Trial | Change |
|---|---|---|
| 2026-06-09 | NCT07310797 Comparison of Mirabegron and Tamsulosin for Ureteral Stone Expulsion |
Recruitment opened |
| 2026-05-16 | NCT05604222 Effect of Behavioral Sleep Intervention on Lower Urinary Tract Symptoms in Older Women |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-05-16 | NCT05604222 Effect of Behavioral Sleep Intervention on Lower Urinary Tract Symptoms in Older Women |
date change Primary completion pushed: 2026-05-31 -> 2026-06-30 |
| 2026-05-15 | NCT05937854 Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH |
date change Primary completion pushed: 2027-06-01 -> 2029-03-01 |
| 2026-05-15 | NCT05937854 Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH |
date change Completion pushed: 2027-12-01 -> 2029-03-01 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-11 | NCT07642505 L-Citrulline and Tadalafil for Mild to Moderate Erectile Dysfunction | Phase 4 | Recruiting |
| 2026-06-09 | NCT07636161 PLEASURE (Pleasing Lovers, Efficacy, Arousal, Satisfaction, and Uptake Research on Eroxon) | Phase 4 | Not Yet Recruiting |
| 2026-06-03 | NCT07623876 Tamsulosin and Intraureteral Aminophylline for Ureteral Access During RIRS | Phase 2 | Recruiting |
| 2026-06-01 | NCT07617909 L-Citrulline Versus Tamsulosin for Medical Expulsive Therapy of Distal Ureteral Stones | Phase 2 | Recruiting |
| 2026-05-22 | NCT07602608 Platelet-Rich Plasma With or Without Tadalafil for Erectile Dysfunction | Phase 4 | Completed |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT05051436 | The Effects of Mirabegron and Tadalafil on Glucose Tolerance in Prediabetics | Pre-diabetes | Recruiting |
| NCT07391579 | Daily Tadalafil 5 mg Combined With On-Demand Sildenafil 100 mg for Treatment of Erectile… | Erectile Dysfunctions | Recruiting |
| NCT07416968 | Randomized Controlled Trial Comparing Low Dose Tadalafil Versus Solifenacin For… | Overactive Bladder (OAB) | Recruiting |
| NCT05362292 | TReating Incontinence for Underlying Mental and Physical Health | Urinary Incontinence, Urge | Recruiting |
| NCT07499804 | Effect of Tadalafil on Endometrial Thickness and Frozen Embryo Transfer Outcomes | IVF | Recruiting |
| NCT07310797 | Comparison of Mirabegron and Tamsulosin for Ureteral Stone Expulsion | Ureteral Calculi | Recruiting |
| NCT07642505 | L-Citrulline and Tadalafil for Mild to Moderate Erectile Dysfunction | Erectile Dysfunction | Recruiting |
| NCT07467343 | Silodosin vs Tamsulosin for LUTS Due to BPH: A Randomized Crossover Trial | Benign Prostatic Hyperplasia | Not Yet Recruiting |
| NCT07187466 | Behavioral and/or Mirabegron to Treat Urinary Symptoms in Parkinson Disease | Overactive Bladder | Not Yet Recruiting |
| NCT05604222 | Effect of Behavioral Sleep Intervention on Lower Urinary Tract Symptoms in Older Women | Urgency Urinary Incontinence | Active, Not Recruiting |
| NCT06465576 | Strategy for Withdrawal of Pharmacological Treatment for Urinary Incontinence in Children… | Urinary Incontinence in Children | Active, Not Recruiting |
| NCT07636161 | PLEASURE (Pleasing Lovers, Efficacy, Arousal, Satisfaction, and Uptake Research on Eroxon) | Type 2 Diabetes | Not Yet Recruiting |
| Phase 3 | |||
| NCT05844462 | Tadalafil for Severe Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease | Pulmonary Hypertension | Recruiting |
| NCT07245680 | COMMODITIES Trial: Initial Dual Oral Therapy vs Monotherapy in PAH With Cardiovascular… | Pulmonary Arterial Hypertension (PAH) | Recruiting |
| NCT06551246 | Efficacy of Solifenacin, Mirabegron and Combination Therapy in Children With Daytime… | Urinary Incontinence in Children | Recruiting |
| NCT07398261 | Efficacy of Mirabegron for Treatment of Non-monosymptomatic Nocturnal Enuresis in Children | Treatment of Non-monosymptomatic Nocturnal Enuresis | Active, Not Recruiting |
| NCT06987383 | Vibegron for ENergy Thinking and Resilience in Aging | Obesity | Not Yet Recruiting |
| NCT05621616 | A Study to Learn How Effective and Safe the Drug 'Mirabegron' is and How Long it Stays in… | Neurogenic Detrusor Overactivity | Active, Not Recruiting |
| Phase 2 | |||
| NCT04666636 | Mechanisms for Activation of Beige Adipose Tissue in Humans | PreDiabetes | Recruiting |
| NCT04597372 | Impact of Tamsulosin on Post-Operative Urinary Retention Following Pelvic Reconstructive… | Urinary Retention Postoperative | Recruiting |
| NCT05937854 | Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH | Chronic Obstructive Pulmonary Disease | Recruiting |
| NCT06290713 | Vasodilator and Exercise Study for DMD (VASO-REx) | Duchenne Muscular Dystrophy | Recruiting |
| NCT07617909 | L-Citrulline Versus Tamsulosin for Medical Expulsive Therapy of Distal Ureteral Stones | Distal Ureteral Stone | Recruiting |
| NCT07623876 | Tamsulosin and Intraureteral Aminophylline for Ureteral Access During RIRS | Renal Stones | Recruiting |
| NCT07566208 | Using Mirabegron to Control Arrhythmia-1 | Ventricular Arrhythmias and Cardiac Arrest | Not Yet Recruiting |